Psoriasis experts discuss updates with TNF inhibitors and how they have changed the treatment landscape for psoriatic disease.
EP. 1: Pathogenesis of PsA and PsO
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss updates in the pathogenesis of PsA and PsO.
EP. 2: Patient Presentation of PsA and PsO
Drs Mark G. Lebwohl and Joseph F. Merola discuss how patient presentation differs in patients with PsO and PsA.
EP. 3: Challenges in Diagnosing Psoriasis
Expert dermatologists discuss challenges in diagnosing a patient with PsA.
EP. 4: Overcoming Diagnostic Delay in Psoriasis
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide tips to overcome diagnostic delay in psoriasis.
EP. 5: Head-to-Head Studies in Psoriasis
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss different head-to-head studies in psoriasis.
EP. 6: Role of Anti-TNF Molecules in PsA and PsO Therapy
Expert dermatologists discuss different anti-TNF molecules and the impact of having these types of molecules on psoriasis and psoriatic arthritis care.
EP. 7: Switching Therapies in Psoriasis
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide insight on when it is appropriate to switch from one biologic to another for a patient with psoriasis.
EP. 8: Biosimilars in Psoriasis
Drs Mark G. Lebwohl and Joseph F. Merola discuss the use of biosimilars in psoriasis and how biosimilars will change the treatment landscape.
EP. 9: Case Presentation: 45-Year-Old Caucasian Male Diagnosed With Psoriasis
Mark G. Lebwohl, MD, presents a case of a 45-year-old Caucasian male diagnosed with psoriasis.
EP. 10: Psoriasis Case Impressions
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
2 Clarke Drive Cranbury, NJ 08512